CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,500 enrolled
Drug / intervention
Implantable defibrillatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00800384
NCT00800384N/ACompleted

Shockless Implant Evaluation

Boston Scientific Corporation·interventional·Posted Dec 2, 2008·Updated Mar 30, 2018

In Brief

A clinical study evaluating Implantable defibrillator for Ventricular Fibrillation and Ventricular Tachycardia. Completed, enrolled 2,500 participants across 85 sites in 18 countries.

Detailed Summary

This trial will assess the safety of defibrillator testing and the influence of defibrillation testing on the efficacy of clinical shocks. The trial will test the hypothesis that implantable cardioverter defibrillator (ICD) implantation without defibrillation testing (DT) is non-inferior to implantation with testing against the composite endpoint of ineffective first appropriate clinical shock or arrhythmic death. It will also test the hypothesis, that defibrillation testing increases the peri-operative (30 days) complication rate of ICD implantation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia, Austria, Canada, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Malaysia, Netherlands, Norway, Poland, Spain, Sweden, Thailand, United Kingdom
CollaboratorsGuidant Corporation

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 2, 2008
Enrollment StartJan 1, 2009
Primary CompletionOct 1, 2013
Study CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 17.6 years ago

Interventions

Implantable defibrillatordevice

Implantable defibrillator to detect and terminate ventricular arrhythmias